Back
Innate Pharma SA Stock Price Chart

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
57
IPHA
Innate Pharma SA
Last Price:
$2.15
Seasonality Move:
-7.89%
7 Day Trial
ALL ACCESS PASS
$
7

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight selling pressure.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.16 | Sell |
20-day SMA: | 2.18 | Sell |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2 | Buy |
8-day EMA: | 2.14 | Sell |
20-day EMA: | 2.14 | Sell |
50-day EMA: | 2.07 | Buy |
200-day EMA: | 2.07 | Buy |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 50.08 | Buy |
Chaikin Money Flow: | -4357 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.98 - 2.28) | Sell |
Bollinger Bands (100): | (1.8 - 2.16) | Buy |
Innate Pharma SA Technical Analysis
May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 2.12 while IPHA 8-day simple moving average is 2.16, which is a Sell signal.
-
The stock price of IPHA is 2.12 while Innate Pharma SA 20-day SMA is 2.18, which makes it a Sell.
-
Innate Pharma SA 50-day simple moving average is 2.02 while IPHA share price is 2.12, making it a Buy technically.
-
IPHA stock price is 2.12 and Innate Pharma SA 200-day simple moving average is 2.00, creating a Buy signal.
IPHA Technical Analysis vs Fundamental Analysis
Buy
57
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a BuyThe current Innate Pharma SA [IPHA] share price is $2.12. The Score for IPHA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Innate Pharma SA Stock Info
Market Cap:
195.4M
Price in USD:
2.12
Share Volume:
18.9K
Innate Pharma SA 52-Week Range
52-Week High:
3.51
52-Week Low:
1.29
Buy
57
Innate Pharma SA (IPHA)
is a Buy
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 2.12 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is not overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 2.12 while IPHA 8-day exponential moving average is 2.14, which is a Sell signal.
-
The stock price of IPHA is 2.12 while Innate Pharma SA 20-day EMA is 2.14, which makes it a Sell.
-
Innate Pharma SA 50-day exponential moving average is 2.07 while IPHA share price is 2.12, making it a Buy technically.
-
IPHA stock price is 2.12 and Innate Pharma SA 200-day simple moving average is 2.07, creating a Buy signal.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Innate Pharma SA is a Buy
-
Innate Pharma SA Relative Strength Index (RSI) is 50.08, which suggest Innate Pharma SA is overbought
-
The Bollinger Bands (25) for Innate Pharma SA is (1.98 - 2.28), which suggest Innate Pharma SA is a Buy
-
The Bollinger Bands (100) for Innate Pharma SA is (1.8 - 2.16), which suggest Innate Pharma SA is a Buy
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.